Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents with Narcolepsy
- Study Title
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
- Teva Identifier
- C10953/1100 | 2012-005510-20
- ClinicalTrials.gov Identifier
- NCT01624480
- Study Status
- Completed
- Trial Condition(s)
- Narcolepsy
- Interventions
- Drug: Armodafinil
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 6 Years to 17 Years
- Trial Duration
- 07/01/2012 - 12/01/2015
- Phase
- Phase 1
